Basel Medical (BMGL) Interest Expenses (2023 - 2025)
Basel Medical (BMGL) posted Interest Expenses of $140506.0 for Q4 2025, up 243.93% sequentially from -$97619.0 in Q4 2024, and up 243.93% YoY from $40852.7 in Q4 2024.
Analysis
Basel Medical (BMGL) Interest Expenses (2023 - 2025) Analysis & Trends
Basel Medical has reported Interest Expenses for 2 years, with the latest figure at $140506.0 in Q4 2025.
- Quarterly Interest Expenses rose 243.93% year-over-year to $140506.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42887.0 (changed N/A YoY) and the FY2025 annual result came in at $160349.0, down 47.55% from the prior year.
- Interest Expenses advanced to $140506.0 in Q4 2025 per BMGL's latest filing, from -$97619.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $140506.0 in Q4 2025 and troughed at -$97619.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 89.17 Bn | 88.15 Bn | 15.19 Bn | 599.00 Mn |
| 2 | Tenet Healthcare | 22.04 Bn | 19.87 Bn | 4.45 Bn | 204.00 Mn |
| 3 | Encompass Health | 12.07 Bn | 11.94 Bn | 1.34 Bn | 32.80 Mn |
| 4 | Davita | 11.84 Bn | 11.16 Bn | 1.16 Bn | 150.26 Mn |
| 5 | Universal Health Services | 10.14 Bn | 10.00 Bn | 3.29 Bn | 39.91 Mn |
| 6 | Ensign | 9.95 Bn | 9.63 Bn | 306.24 Mn | 1.93 Mn |
| 7 | Chemed | 6.85 Bn | 6.81 Bn | 221.47 Mn | 21.79 Mn |
| 8 | Pacs | 6.77 Bn | 6.61 Bn | 338.46 Mn | 6.04 Mn |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.15 Bn | 192.10 Mn | - |
| 10 | Basel Medical | 7.33 Mn | 6.54 Mn | - | -215,784.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -215,784.00 |
| Jun 30, 2025 | 848,452.00 |
| Dec 31, 2024 | -97,619.00 |
| Dec 31, 2023 | -96,123.00 |